COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev

Curative Inc., created in January 2020 with the intent of improving diagnostics for sepsis, pivoted to SARS-CoV-2 testing in March 2020 as it became clear that the United States needed additional testing capacity. Cell Systems spoke with Curative cofounders Fred Turner, Dr. Isaac Turner, and Dr. Vla...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2020
Materias:
Q&A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577258/
http://dx.doi.org/10.1016/j.cels.2020.09.010
_version_ 1783598164273528832
collection PubMed
description Curative Inc., created in January 2020 with the intent of improving diagnostics for sepsis, pivoted to SARS-CoV-2 testing in March 2020 as it became clear that the United States needed additional testing capacity. Cell Systems spoke with Curative cofounders Fred Turner, Dr. Isaac Turner, and Dr. Vlad Slepnev about their work developing and deploying a COVID-19 oral fluid test at scale with unprecedented speed.
format Online
Article
Text
id pubmed-7577258
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-75772582020-10-22 COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev Cell Syst Q&A Curative Inc., created in January 2020 with the intent of improving diagnostics for sepsis, pivoted to SARS-CoV-2 testing in March 2020 as it became clear that the United States needed additional testing capacity. Cell Systems spoke with Curative cofounders Fred Turner, Dr. Isaac Turner, and Dr. Vlad Slepnev about their work developing and deploying a COVID-19 oral fluid test at scale with unprecedented speed. Cell Press 2020-10-21 2020-10-21 /pmc/articles/PMC7577258/ http://dx.doi.org/10.1016/j.cels.2020.09.010 Text en
spellingShingle Q&A
COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev
title COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev
title_full COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev
title_fullStr COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev
title_full_unstemmed COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev
title_short COVID-19 Testing at Scale while Reimagining Healthcare: An Interview with Curative Cofounders Fred Turner, Isaac Turner, and Vlad Slepnev
title_sort covid-19 testing at scale while reimagining healthcare: an interview with curative cofounders fred turner, isaac turner, and vlad slepnev
topic Q&A
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577258/
http://dx.doi.org/10.1016/j.cels.2020.09.010

Ejemplares similares